Defective RNA Polymerase III sensing of mitochondrial DNA in pulmonary epithelial cells impairs type I IFN immunity to SARS-CoV-2
The clinical spectrum of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection ranges from asymptomatic cases to critical COVID-19 pneumonia. To investigate the role of host genetics in susceptibility to critical COVID-19 and identify pathophysiological mechanisms and pathways, we analyzed whole-exome and whole-genome sequencing data from the COVID Human Genetic Effort. We identified 10 rare, monoallelic predicted loss-of-function variants in 18 patients in <i>POLR3A</i> and <i>POLR3C</i> encoding two subunits of RNA polymerase III (POL III), a nuclear multisubunit enzyme, which has been implicated in cytosolic DNA sensing. These variants were deleterious for expression of full-length POLR3A and POLR3C proteins. We demonstrate that human pulmonary A549-hACE2 cells with reduced POLR3A or POLR3C expression exhibit impaired type I IFN responses to transfected mitochondrial DNA (mtDNA) or SARS-CoV-2 infection, together with increased viral replication. Mechanistically, we show that SARS-CoV-2 induces cellular mtDNA release via oligomerization of the mitochondrial voltage-dependent anion channel under virus-induced oxidative stress, enabling POL III-mtDNA interaction. These findings establish POL III as a sensor of endogenous mtDNA released during viral infection and indicate that autosomal dominant POL III haploinsufficiency may predispose individuals to critical COVID-19.
Authors
- Rebeca Pérez de Diego (ORCID: https://orcid.org/0000-0001-8426-8765)
- Daniëla Maria Hinke (ORCID: https://orcid.org/0000-0002-3932-8762)
- Fernanda Sales Luiz Vianna (ORCID: https://orcid.org/0000-0001-6339-4869)
- Sofie E. Jørgensen (ORCID: https://orcid.org/0000-0002-2700-0882)
- Pierre Hausfater
- Florence Tubach (ORCID: https://orcid.org/0000-0002-7802-944X)
- Q. Zhang
- Hua Su (ORCID: https://orcid.org/0000-0003-2344-3886)
- Thomas Zillinger (ORCID: https://orcid.org/0000-0002-0866-4835)
- Laurent Abel (ORCID: https://orcid.org/0000-0001-7016-6493)
- CoV-Contact Cohort
- French COVID Cohort Study Group
- Shen-Ying Zhang
- CHRISTIAN KANSTRUP HOLM
- Jade Ghosn
- Cedric Laouenan
- Michelle Møhlenberg
- Anne Kruse Hollensen
- Anne Louise Hansen
- Trine H. Mogensen
- Jean-Laurent Casanova
- Aurora Pujol
- NIAID-USUHS COVID Study Group
- Guy Gorochov
- Merete Storgaard
- COVIDeF Study Group
- Amsterdam UMC COVID-19 Biobank
- Aurélie Cobat
- COVID Human genetic Effort
- COVID-19 DNABR Group
- Renée Marije van der Sluis
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Universidade Federal do Rio Grande do Sul (BR)
- Inserm (FR)
- Aarhus University (DK)
- Université Paris Cité (FR)
- University Hospital Bonn (DE)
- Great Ormond Street Hospital (GB)
- Hospital for Sick Children (CA)
- Bellvitge University Hospital (ES)
- Aarhus University Hospital (DK)
- Sorbonne Université (FR)
- Hospital de Clínicas de Porto Alegre (BR)
- Hospital La Paz Institute for Health Research (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Institute for Biomedicine (IT)
- Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR)
- National Institute of Allergy and Infectious Diseases (US)
- SickKids Foundation (CA)
- Hôpital Bichat-Claude-Bernard (FR)
- Institut des Maladies Génétiques Imagine (FR)
- Ekaterinburg Research Institute of Viral Infections (RU)
- University College London (GB)
- Rockefeller University (US)
- University of Rio Grande and Rio Grande Community College (US)
Publication Details
- Journal
- Proceedings of the National Academy of Sciences
- Published
- 2026-03-16
- DOI
- https://doi.org/10.1073/pnas.2522111123
- Primary Topic
- interferon and immune responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00